Abstract Library

#3223 Telemedicine: A good tool to improve health care in NEN´s patient during the COVID19 pandemic. A multicenter series experience of a NET multidisciplinary team in Argentina

Introduction: COVID-19 pandemic has infected nearly 55,078,170 individuals with 1,328,262 deaths since first identified in the human population in December 2019 in Wuhan, China. Global all-cause morbidity and mortality have increased due to the low availability of Global Health Care Services. The new challenge is to maintain high standards of care.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Oviedo A

Authors: Oviedo Albor A, Maquieria J, Eleta M, Rizzolo M, Basso S,

Keywords: telemedicine, covid-19, NETS, Argentina,

#1848 Liver Metastatic Disease (LMD) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): Incidence, Treatment and Survival in a Multicenter Study in Argentina. Preliminary Report. ARGENTUM GROUP

Introduction: The first observational Study from our Group in Argentina, showed 60% incidence of liver mets at initial diagnosis. The treatment encompasses a wide scope of surgical and non-surgical modalities.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: O´Connor J

Authors: O'Connor J, Sanchez Loria F, Fauda M, Montal S, Podestá G,

Keywords: Liver, NETs,

#1147 Correlation of Serum Plasma Chromogranin A with Survival and Disease Features in Patients with Gastroenteropancreatic Neuroendocrine Tumors. First Results in a Large Database in Argentina. ARGENTUM GROUP.

Introduction: The plasma chromogranin A (CgA) is the best general biomarker in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). CrA levels are elevated in a variety of GEP-NETs and are used to aid in diagnosis, prognosis, and monitoring of treatment effects in this population.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Belli S

Authors: Belli S, O'Connor J, Oneto A, Pesce V, Bestani C,

Keywords: neuroendocrine tumor, chromogranin A, prognostic factor ,

#854 Scoping Study on Quality of Life (QL) in Patients (pts) with Neuroendoncrine Tumors (NET) of the Digestive Tract in Argentina: Preliminary Results

Introduction: Patients with NET compound a specific cancer population: their survival used to be longer than other cancer patient populations and they received drugs (eg. somatostatin analogues) rarely used on others. The systematic measure of QL in these patients could lead to better understanding of the impact of the disease and treatments, not only in terms of symptom prevalence but also in relation to daily concerns.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: PESCE V

Authors: Grance G, Pesce V, Bestanti C, O'Connor J, Roca E,

Keywords: NET, quality of life, symptom burden, supportive care,

#715 Neuroendocrine Tumors of the Rectum: Experience in Argentina

Introduction: Neuroendocrine tumors (NETs) of the rectum have been increasing in incidence. They are approximately 18% the all NETs and 27% of all gastrointestinal NETs. Rectal NETs are usually small and are often found incidentally during endoscopy. Patients (pts) with local disease have a favorable prognosis of a 5-year survival rate of 88-91%. Optimal treatment of NETs of the rectum has been widely debated.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Bestani C, Pesce V, O'Connor J, Cabanne A, Mendez G,

Keywords: rectal NETs,